CP and irritable bowel syndrome: Calprotectin (CP) in feces has emerged as a promising biomarker for IBD diagnostics particularly in UC, with excellent sensitivity (92.6%) and specificity (88.9%), allowing clinicians to not only distinguish CD from UC as levels of fecal CP are much lower in CD, but also distinguish IBD from other conditions such as irritable bowel syndrome.5